PTPI (Petros Pharmaceuticals, Inc.) Forvard P/S multiplikatori

Petros Pharmaceuticals, Inc. (PTPI) korporativ emblemasi va logotipi

Petros Pharmaceuticals (PTPI) uchun prognoz qilinayotgan P/S baholashi, ushbu grafikda GURU.Markets ma'lumotlari bilan ko'rsatilganidek, erkaklar salomatligi patentlari va FDA ning qat'iy nazoratining ta'sirini tasdiqlaydi. Shu bilan birga, 0.20 darajasi muhim mezon vazifasini o'taydi. Biznes samaradorligi xarajatlarni kamaytirish uchun ishlab chiqarishni CMOlar orqali autsorsing qilishga asoslangan, daromadlar hajmini oshirish esa iste'molchilarga to'g'ridan-to'g'ri raqamli savdo tizimini rivojlantirishga bog'liq.

PTPI (Petros Pharmaceuticals, Inc.) Narxning kutilayotgan daromadga nisbati tarixi 04.07.2022dan 28.06.2025gacha

PTPI (petrospharma.com): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

- bozor narxi va tahlilchilarning maqsadli narxlari:
- biznesning bozor baholash ko'rsatkichlari:
Kompaniyaning har tomonlama tahlili:Petros (PTPI)
Petros Pharmaceuticals original mahsuloti

Faoliyati qat'iy ravishda FDA standartlari bilan tartibga solinadigan biofarmatsevtika kompaniyasi Petros Pharmaceuticals (PTPI) uchun asosiy qiymat drayveri uning mahsulotlarining kutilayotgan tijoratlashtirilishidir. Forward P/S koeffitsiyenti joriy bozor kapitalizatsiyasini prognoz qilingan yillik daromad bilan solishtiradi, bu esa investorlarga hissiy shovqinlarni filtrlash va aktivlarning adolatli qiymatini aniqlash imkonini beradi, shuningdek, biznes salohiyati past baholangan paytlarda kirish nuqtalarini aniqlash uchun ushbu grafikdan foydalanish imkonini beradi.

Muhim raqobatchilar

Forvard P/S multiplikatori HLN (Haleon PLC)|Forvard P/S multiplikatori Kenvue Corp KVUE|Verona Pharma PLC - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati jyongbio.com|LGND: Forvard P/S multiplikatori|Kapitalizatsiyaning prognoz qilingan daromadga nisbati AMRX|Narxning prognoz qilingan daromadga nisbati Perrigo Company|Bozor kapitallashuvining kelajakdagi daromadga nisbati Alvotech ALVO|Forvard P/S multiplikatori LQDA|GLPG: Kelajakdagi narxning daromadga nisbati|Forvard P/S multiplikatori ANIP (ANI Pharmaceuticals, Inc.)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati MannKind Corp (MNKD)|AMPH: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx PCRX (Pacira)|ARS Pharmaceuticals (SPRY) - Narxning prognoz qilingan daromadga nisbati|Kapitalizatsiyaning prognoz qilingan daromadga nisbati TBPH|AQST (Aquestive Corp) - Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori scPharmaceuticals Inc. (SCPH)|Forvard narx/daromad multiplikatori TECX (Tectonic Therapeutic, Inc.)|TNXP (Tonix Pharmaceuticals Holding) - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati SXT Pharmaceuticals SXTC|Sotuvga nisbatan forvard narx EPRX|BHST - Narxning prognoz qilingan daromadga nisbati|eXoZymes (EXOZ) - Forvard narx/daromad multiplikatori|ORMP: Forvard P/S multiplikatori|ENTX: Narxning kutilayotgan daromadga nisbati|HYFT (ipatherapeutics.com) - Forvard P/S multiplikatori|Forvard P/S multiplikatori ABVC BioPharma|Narxning prognoz qilingan daromadga nisbati Cumberland Pharmaceuticals Inc. (CPIX)|QNTM (Quantum BioPharma Ltd.) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori FGEN (fibrogen.com)|Telomir Pharmaceuticals (TELO) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|RANI - Narxning prognoz qilingan daromadga nisbati|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Synergy CHC SNYR|RLYB: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Lexaria (LEXX)|Narxning prognoz qilingan daromadga nisbati Pulmatrix|Kapitalizatsiyaning prognoz qilingan daromadga nisbati PTHL (ftzy.com.cn)|Forvard P/S multiplikatori APM|Lyra Therapeutics, Inc. - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Forvard P/S multiplikatori IBO (impactbiomedinc.com)|TNFA: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|YCBD - Narxning prognoz qilingan daromadga nisbati|PRFX - Forvard P/S multiplikatori|CYTO (altamiratherapeutics.com) - Forvard narx/daromad multiplikatori|LIPO - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard narx/daromad multiplikatori OPTN|Pieris Pharmaceuticals Inc (PIRS) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard P/S multiplikatori PROC|Forvard P/S multiplikatori Qilian International Corp (QLI)|ACELYRIN, Inc. - Forvard narx/daromad multiplikatori|Forvard P/S multiplikatori tffpharma.com TFFP